(Q53347926)

13 May 2018

title

Cyclin E expression is correlated with tumor progression and predicts a poor prognosis in patients with ovarian carcinoma. (English)

1 reference

13 May 2018

0 references

1 reference

4

Anais Malpica

1 reference

13 May 2018

6

Gordon B Mills

1 reference

13 May 2018

author name string

Daniel G Rosen

1

1 reference

13 May 2018

Gong Yang

2

1 reference

13 May 2018

Michael T Deavers

3

1 reference

13 May 2018

John J Kavanagh

5

1 reference

13 May 2018

Jinsong Liu

7

1 reference

13 May 2018

language of work or name

English

0 references

publication date

1 May 2006

1 reference

13 May 2018

published in

Cancer

1 reference

13 May 2018

volume

106

1 reference

13 May 2018

issue

9

1 reference

13 May 2018

page(s)

1925-1932

1 reference

13 May 2018

Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21767

Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21767

Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21767

Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is associated with advanced stage and invasiveness of gastric carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21767

Frequent amplification of the cyclin E gene in human gastric carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21767

Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21767

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21767

7 January 2021

Cyclin E and survival in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21767

7 January 2021

Expression of cyclin E and cyclin-dependent kinase 2 correlates with metastasis and prognosis in colorectal carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21767

7 January 2021

Expression and prognostic value of the cell-cycle regulatory proteins, Rb, p16MTS1, p21WAF1, p27KIP1, cyclin E, and cyclin D2, in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21767

7 January 2021

Implication of malignancy and prognosis of p27(kip1), Cyclin E, and Cdk2 expression in epithelial ovarian tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21767

7 January 2021

Expression of cell cycle regulators p57KIP2, cyclin D1, and cyclin E in epithelial ovarian tumors and survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21767

7 January 2021

The pathological assessment of ovarian neoplasms. II: The proliferating ‘epithelial’ tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21767

7 January 2021

The pathological assessment of ovarian neoplasms. III: The malignant ‘Epithelial’ tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21767

7 January 2021

The pathological assessment of ovarian neoplasms. i: introduction to the common ‘epithelial’ tumours and analysis of benign ‘epithelial’ tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21767

7 January 2021

Grading ovarian serous carcinoma using a two-tier system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21767

7 January 2021

Relapsed ovarian cancer: challenges and management strategies for a chronic disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21767

7 January 2021

Defining progression of ovarian carcinoma during follow-up according to CA 125: a North Thames Ovary Group Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21767

7 January 2021

Epithelial ovarian carcinoma: principles of primary surgery

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21767

7 January 2021

The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21767

7 January 2021

Validation of tissue microarray technology in ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21767

7 January 2021

The concurrent expression of p27(kip1) and cyclin D1 in epithelial ovarian tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21767

7 January 2021

Prognostic value of cyclin E and p53 expression in gastric carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21767

7 January 2021

Prognostic significance of cell cycle proteins and genomic instability in borderline, early and advanced stage ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21767

7 January 2021

Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21767

7 January 2021

Novel splice variants of cyclin E with altered substrate specificity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21767

7 January 2021

Cyclin E in breast tumors is cleaved into its low molecular weight forms by calpain.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21767

7 January 2021

Tumor-specific proteolytic processing of cyclin E generates hyperactive lower-molecular-weight forms

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21767

7 January 2021

Cyclin E deregulation alters the biologic properties of ovarian cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21767

7 January 2021

Less expression of cyclin E in cutaneous squamous cell carcinomas than in benign and premalignant keratinocytic lesions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21767

7 January 2021

Molecular characterization of intraductal breast carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21767

7 January 2021

Deregulated cyclin E induces chromosome instability

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21767

7 January 2021

Correlation between MIB1-determined tumor growth fraction and incidence of tumor recurrence in early ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21767

7 January 2021

Identifiers

DOI

10.1002/CNCR.21767

1 reference

13 May 2018

PubMed ID

16568440

1 reference

13 May 2018